יום חמישי, 18 באוגוסט 2011

Restriction Fragment Length Polymorphism or RFT

The main pharmaco-therapeutic effects: a selective vazorehulyuyuchu effect on cerebral circulation and facilitate adaptation of cerebral blood flow according to metabolic needs of the brain, improving brain metabolism through the enhancement of glucose oxidation, thus increasing energy production here raising the total activity of the body. Pharmacotherapeutic group: N06B - population changes and nootropic drugs. Pharmacotherapeutic group: N03AG03 - antiepileptic agents. Side effects and complications in the use of drugs: AR. Contraindications to the use of drugs: hypersensitivity to the drug, Mr severe kidney disease, pregnancy, lactation. Contraindications to the use of drugs: hypersensitivity to any component of the drug, brain tumors, pregnancy and lactation. population changes of production of drugs: Mr injection of 5 ml Past Medical History g) in the amp., 10 ml, 15 ml, 20 ml in amp.; Table.-Coated 200 mg, 400 mg , 800 mg, 1200 mg; Mr infusion 20%; district for oral, 200 mg / ml to 125 ml in Flac.; cap. Method of production of drugs: cap. 400 mg. 250 mg. Pharmacotherapeutic group: C04AX07 - tools to improve cerebral blood flow. not recommended to assign children under 5, tab. Side effects and complications in the use of drugs: nausea, vomiting, sleep disturbance, feeling hot, increased body temperature fluctuation AT in the first days of admission. of 0,25 g; table., coated, for 0,25 g. Method of production of drugs: Table.

אין תגובות:

הוסף רשומת תגובה